
Nancy Lynn Lewis MD
Associate Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ
Join to View Full Profile
925 Chestnut StSte 320aPhiladelphia, PA 19107
Phone+1 215-955-8874
Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
- University of Rochester Medical CenterResidency, Internal Medicine, 1994 - 1997
- Lewis Katz School of Medicine at Temple UniversityClass of 1994
Certifications & Licensure
- PA State Medical License 1997 - 2026
- NJ State Medical License 2008 - 2025
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsFirst-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with adv...Rom Leidner, Kevin Conlon, Douglas G McNeel, Andrea Wang-Gillam, Sumati Gupta
Journal for Immunotherapy of Cancer. 2023-10-01 - 59 citationsCombination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase...Funda Meric-Bernstam, Randy F Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia
Clinical Cancer Research. 2023-01-04 - 133 citationsPhase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients With Advanced/Metastatic Solid Tumors or Lymphomas.Funda Meric-Bernstam, Randy F. Sweis, F. Stephen Hodi, Wells A. Messersmith, Robert H.I. Andtbacka
Clinical Cancer Research. 2021-10-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: